- Home
- HIVE vs CYRX Comparison
HIVE vs CYRX Comparison
Compare HIVE & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIVE
- CYRX
- Stock Information
- Founded
- HIVE 1987
- CYRX 1999
- Country
- HIVE Canada
- CYRX United States
- Employees
- HIVE N/A
- CYRX N/A
- Industry
- HIVE
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- HIVE
- CYRX Health Care
- Exchange
- HIVE Nasdaq
- CYRX Nasdaq
- Market Cap
- HIVE 368.3M
- CYRX 422.6M
- IPO Year
- HIVE N/A
- CYRX N/A
- Fundamental
- Price
- HIVE $2.00
- CYRX $6.23
- Analyst Decision
- HIVE Strong Buy
- CYRX Buy
- Analyst Count
- HIVE 7
- CYRX 7
- Target Price
- HIVE $7.79
- CYRX $13.14
- AVG Volume (30 Days)
- HIVE 10.5M
- CYRX 376.2K
- Earning Date
- HIVE 02-11-2025
- CYRX 03-04-2025
- Dividend Yield
- HIVE N/A
- CYRX N/A
- EPS Growth
- HIVE N/A
- CYRX N/A
- EPS
- HIVE N/A
- CYRX N/A
- Revenue
- HIVE $120,999,000.00
- CYRX $228,385,000.00
- Revenue This Year
- HIVE $2.40
- CYRX $9.31
- Revenue Next Year
- HIVE $179.59
- CYRX $8.36
- P/E Ratio
- HIVE N/A
- CYRX N/A
- Revenue Growth
- HIVE 26.29
- CYRX N/A
- 52 Week Low
- HIVE $1.78
- CYRX $4.58
- 52 Week High
- HIVE $5.54
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- HIVE 29.85
- CYRX 46.49
- Support Level
- HIVE $1.84
- CYRX $4.58
- Resistance Level
- HIVE $2.29
- CYRX $6.39
- Average True Range (ATR)
- HIVE 0.19
- CYRX 0.54
- MACD
- HIVE -0.03
- CYRX 0.07
- Stochastic Oscillator
- HIVE 19.64
- CYRX 64.71
About HIVE HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.